While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

AI can be a powerful tool in research, but it’s not the be-all, end-all—and a new study led by Amer Alam, PhD, associate ...

Summer begins early in Hollywood, on the first weekend in May and that kick-off can make or break that pivotal 123 day ...

Stocks closed higher Tuesday to extend a week-long rally as investors digested a flurry of earnings reports from major ...

Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...

Former officials are asking lawmakers to investigate role that Trump’s DEA pick played in deadly overseas incidents.

The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.

Key Takeaways Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...

Attorney General Pam Bondi traveled to a Drug Enforcement Administration lab to meet with chemists who are tasked with ...

DC isn’t the only place where regulatory burden-boosting policy proposals are garnering bipartisan support. The same ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...